General Pharmacology: The Vascular System
Review articleFlavonoids and the inhibition of PKC and PI 3-kinase
Section snippets
PI 3-kinases
Phosphoinositide 3-kinases are a family of enzymes that specifically catalyze the phosphorylation of inositol lipids in the D3 position of the inositol ring, generating new intracellular lipid second messengers (Fig. 2). These enzymes are activated by a large number of agonist-stimulated cell-surface receptors (Hawkins et al., 1997). It is now well established that PI 3-kinases play an essential role in cell signaling and in the regulation of a number of cellular functions, including
PI 3-kinase and flavonoids
Two PI 3-kinase inhibitors have proved valuable reagents in the discovery of several downstream effectors of these lipid kinases. The first commonly used is the fungal metabolite wortmannin, an irreversible inhibitor that seems to be quite specific at low concentrations (<20 nM). However, at higher concentrations, this compound has other targets in the cell. The second inhibitor is LY294002, a chromome synthetized using quercetin as a model (Vlahos et al., 1994). This compound competes with ATP
Pkcs
First described as a serine/threonine kinase activated by proteolysis (Takai et al., 1977), PKC was then characterized as a diacylglycerol- and phosphatidylserine-activated kinase. Its identification as the cellular receptor for tumor-promoting phorbol esters (Blumber, 1988) was at the origin of studies implicating the enzyme in growth control, differentiation, and tumorigenesis Nishizuka 1984, Nishizuka 1992. However, PKC was also described as a key regulator of various cellular responses
PKC and flavonoids
Certain flavonoids were found to inhibit various 12-o-tetradecanoylphorbol-13-acetate (TPA)-induced cellular effects such as tumor promotion (Fujiki et al., 1986). Because PKC is considered the cellular receptor for TPA and mediates the cellular effects of this compound, the direct inhibition of purified PKC by various flavonoids was investigated Agullo et al. 1997, Ferriola et al. 1989. From these studies, flavones and flavonols appeared to be the most potent PKC (as well as PI 3-kinase)
References (51)
- et al.
Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation
Biochem Pharmac
(1989) - et al.
Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells)
Cancer Lett
(1996) - et al.
Relationship between flavonoid structure and inhibition of phosphatidylinositol-3 kinasea comparison with tyrosine kinase and protein kinase C inhibition
Biochem Pharmac
(1997) - et al.
Genistein, a specific inhibitor of tyrosine-specific protein kinases
J Biol Chem
(1987) - et al.
Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phaseeffect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1
Biochem Biophys Res Commun
(1998) - et al.
Molecular mechanisms in the antiproliferative action of quercetin
Life Sci
(1997) - et al.
Protein kinase C inhibition by plants flavonoidskinetic mechanisms and structure-activity relationships
Biochem Pharmac
(1989) - et al.
Effects of flavonoids on rat aortic smooth muscle contractilitysturcture-activity relationship
Gen Pharmac
(1996) - et al.
Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL 60 cells
Life Sci
(1994) - et al.
Absorption and disposition kinetics of the dietary antioxidant quercetin in man
Free Radical Biol Med
(1996)